Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EADO 2018 /
Molecular stratification of melanoma and the high burden of mutations

6th - 9th Nov 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.18
Views: 657

Dr Joan Anton Puig Butille - Hospital Clínic de Barcelona, Barcelona, Spain

Dr Joan Anton Puig Butillé speaks with ecancer at the EADO 2018 congress in Barcelona about the molecular stratification of melanoma and that the disease has a high burden of mutations.

Dr Puig Butillé explains molecular characterisation using NGS sequencing found that there are distant subsets of melanoma in addition to this high burden.

He states that this can be useful to decipher which patients will respond well to different treatments.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation